Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics

Experimental and Molecular Medicine

Volumn 44, Issue 9, 2012, Pages 545-553

  Oh, Jee Eun ^a   Cho, Yoon Mi ^a   Kwak, Su Nam ^a   Kim, Jae Hyun ^b   Lee, Kyung Won ^a   Jung, Hyosan ^a   Jeong, Seong Whan ^a   Kwon, Oh Joo ^a  

^a The Catholic University of Korea   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Adipocytes; Adipogenesis; Antipsychotic agents; Brown; Human; PPAR gamma; PRDM16 protein

Indexed keywords

ADIPONECTIN; CLOZAPINE; LEPTIN; MESSENGER RNA; QUETIAPINE; RESISTIN; ZIPRASIDONE;

ACC GENE; ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; AP2 GENE; ARTICLE; BROWN ADIPOSE TISSUE; C EBPBETA GENE; CD36 GENE; CELL DIFFERENTIATION; CELL VIABILITY; CIDEA GENE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE; GENE EXPRESSION; GLUT4 GENE; GROWTH INHIBITION; LIPOGENESIS; METABOLIC DISORDER; MOUSE; NONHUMAN; PGC 1ALPHA GENE; PPARGAMMA2 GENE; PRDM16 GENE; PROADIPOCYTE; SCD1 GENE; TRANSCRIPTION REGULATION; UCP 1 GENE; WEIGHT GAIN;

EID: 84867115811     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2012.44.9.062     Document Type: Article

References (46)

1. Bickel MH, Graber BE, Moor M. Distribution of chlorpromazine and imipramine in adipose and other tissues of rats. Life Sci 1983;33:2025-31
2. Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007;68:917-23
3. Blessing WW, Zilm A, Ootsuka Y. Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats. Neuroscience 2006;141:2067-73
4. Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TA, Kitzrow W, Büttner S, Ehrlich S, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ, Puls I. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2012;38:134-41
5. Cheng YF, Lundberg T, Bondesson U, Lindström L, Gabrielsson J. Clinical pharmacokinetics of clozapine in chronic schizophrenic patients. Eur J Clin Pharmacol 1988; 34:445-9
6. Cho YW, Hong S, Jin Q, Wang L, Lee JE, Gavrilova O, Ge K. Histone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesis. Cell Metab 2009;10:27-39
7. Deng C, Weston-Green K, Huang XF. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1-4
8. Hauner H, Röhrig K, Hebebrand J, Skurk T. No evidence for a direct effect of clozapine on fat-cell formation and production of leptin and other fat-cell-derived factors. Mol Psychiatry 2003;8:258-9
9. Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011;44:195-235
10. Hu Y, Kutscher E, Davies GE. Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells. Phytother Res 2010;24:1831-8
11. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009;460:1154-8
12. Kajimura S, Seale P, Spiegelman BM. Transcriptional control of brown fat development. Cell Metab 2010;11:257-62
13. Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein HH, Klein J. Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. J Endocrinol 2002;175:185-91
14. Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003;28:519-26
15. Lane HY, Chang YC, Chang WH, Lin SK, Tseng YT, Jann MW. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 1999;60:36-40
16. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899-907
17. Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 2012;17:242-66
18. Markowitz JS, Gill HS, DeVane CL, Mintzer JE. Fluoroquinolone inhibition of clozapine metabolism. Am J Psychiatry 1997; 153:881
19. Matsui-Sakata A, Ohtani H, Sawada Y. Receptor occupancybased analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet 2005;20:368-78
20. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Stroup T, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005;80:19-32
21. Monteleone P, Fabrazzo M, Tortorella A, La Pia S, Maj M. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment. J Clin Psychopharmacol 2002;22:424-6
22. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007;293:E444-52
23. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19(Suppl 1):1-93
24. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 2007;68(Suppl 1):20-7
25. Nisoli E, Cardile A, Bulbarelli A, Tedesco L, Bracale R, Cozzi V, Morroni M, Cinti S, Valerio A, Carruba MO. White adipocytes are less prone to apoptotic stimuli than brown adipocytes in rodent. Cell Death Differ 2006;13:2154-6
26. Okamatsu-Ogura Y, Nio-Kobayashi J, Iwanaga T, Terao A, Kimura K, Saito M. Possible involvement of uncoupling protein 1 in appetite control by leptin. Exp Biol Med (Maywood) 2011;236:1274-81
27. Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerbäck S, Virtanen KA. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab 2011;14: 272-9
28. Panariello F, Perruolo G, Cassese A, Giacco F, Botta G, Barbagallo AP, Muscettola G, Beguinot F, Formisano P, de Bartolomeis A. Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. J Cell Physiol 2012;227:1485-92
29. Park S, Kim MS, Namkoong C, Park MH, Hong JP. The effect of ziprasidone on body weight and energy expenditure in female rats. Metabolism 2012;61:787-93
30. Pavan C, Vindigni V, Michelotto L, Rimessi A, Abatangelo G, Cortivo R, Pinton P, Zavan B. Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β. Pharmacogenomics J 2010;10:408-17
31. Rodríguez de la Concepción ML, Yubero P, Iglesias R, Giralt M, Villarroya F. Lithium inhibits brown adipocyte differentiation. FEBS Lett 2005;579:1670-4
32. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527-9
33. Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, Tavernier G, Langin D, Spiegelman BM. Transcriptional control of brown fat determination by PRDM16. Cell Metab 2007;6:38-54
34. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scimè A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008;454:961-7
35. Sertié AL, Suzuki AM, Sertié RA, Andreotti S, Lima FB, Passos-Bueno MR, Gattaz WF. Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1884-90
36. Shader RI, Greenblatt DJ. Clozapine and fluvoxamine, a curious complexity. J Clin Psychopharmacol 1998;18:101-2
37. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008;454: 1000-4
38. Van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009;360:1500-8
39. Viengchareun S, Zennaro MC, Pascual-Le Tallec L, Lombes M. Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Lett 2002;532: 345-50
40. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Hoeks J, Schrauwen P, van Marken Lichtenbelt WD. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2012;97:E1229-33
41. Wang H, Peiris TH, Mowery A, Le Lay J, Gao Y, Greenbaum LE. CCAAT/enhancer binding protein-beta is a transcriptional regulator of peroxisome-proliferator-activated receptorgamma coactivator-1alpha in the regenerating liver. Mol Endocrinol 2008;22:1596-605
42. Wang Q, Zhang M, Ning G, Gu W, Su T, Xu M, Li B, Wang W. Brown adipose tissue in humans is activated by elevated plasma catecholamines levels and is inversely related to central obesity. PLoS One 2011;6:e21006
43. Yang X, Enerbäck S, Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 2003;11:1182-91
44. Yang LH, Chen TM, Yu ST, Chen YH. Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells. Pharmacol Res 2007;56:202-8
45. Yang Z, Yin JY, Gong ZC, Huang Q, Chen H, Zhang W, Zhou HH, Liu ZQ. Evidence for an effect of clozapine on the regulation of fat-cell derived factors. Clin Chim Acta 2009; 408:98-104
46. Zhang JH, Li NF, Yan ZT, Zhang de L, Wang HM, Guo YY, Ling Z. Association of genetic variations of PRDM16 with metabolic syndrome in a general Xinjiang Uygur population. Endocrine 2012;41:539-41